title: Spontaneous regression of colonic lymphoma following infliximab and azathioprine withdrawal in patients with Crohn's disease.
authors: Ann D
authors: AD
authors: Flynn
authors: Jose M
authors: JM
authors: Azar
authors: Michael V
authors: MV
authors: Chiorean
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects*; D003110:Colonic Neoplasms / Q000139:chemically induced / Q000517:prevention & control* / Q000628:therapy; D003113:Colonoscopy; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D016403:Lymphoma, Large B-Cell, Diffuse / Q000139:chemically induced / Q000517:prevention & control* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D016737:Proctocolectomy, Restorative; D012074:Remission Induction; D016896:Treatment Outcome; D028761:Withholding Treatment
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab; D001379:Azathioprine